Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Edgewise Therapeutics Inc
(NQ:
EWTX
)
18.98
+0.25 (+1.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edgewise Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Edgewise Therapeutics to Present at the PPMD Annual Conference and the New Directions in Biology and Disease of Skeletal Muscle Conference
June 22, 2021
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 01, 2021
From
Edgewise Therapeutics, Inc.
Via
Business Wire
Edgewise Therapeutics Reports First Quarter 2021 Financial Results and Recent Highlights
May 13, 2021
From
Edgewise Therapeutics
Via
Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Edgewise Therapeutics Announces Publication of Data Demonstrating the Elevation of Fast but Not Slow Skeletal Muscle Fiber Injury Biomarkers in the Circulation of Patients with Becker and Duchenne Muscular Dystrophy
May 04, 2021
From
Edgewise Therapeutics
Via
Business Wire
Edgewise Therapeutics Appoints Joanne Donovan, M.D., Ph.D., as Chief Medical Officer
April 27, 2021
From
Edgewise Therapeutics
Via
Business Wire
2 Juicy Biotech Stocks to Consider Buying Right Now
April 20, 2021
They're both innovating in attractive areas where there's no competition on the radar.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021
April 20, 2021
Upgrades Compass Point upgraded the previous rating for Newtek Business Services Corp (NASDAQ:NEWT) from Neutral to Buy. For the fourth quarter, Newtek Business Services...
Via
Benzinga
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
April 17, 2021
The FDA and CDC announced their recommendation to pause the use of Johnson & Johnson's JNJ COVID-19 vaccine following incidences of severe clots. J&J's pain turned into gains for other COVID-19 vaccine...
Via
Talk Markets
Exposures
COVID-19
Product Safety
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
April 17, 2021
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2021
April 19, 2021
Upgrades Compass Point upgraded the previous rating for Santander Consumer USA Holdings Inc (NYSE:SC) from Neutral to Buy. In the fourth quarter, Santander Consumer USA...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.